Viewing Study NCT02187133


Ignite Creation Date: 2025-12-25 @ 2:43 AM
Ignite Modification Date: 2026-02-23 @ 9:22 PM
Study NCT ID: NCT02187133
Status: COMPLETED
Last Update Posted: 2021-04-23
First Post: 2014-07-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Carfilzomib With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
Sponsor: University of California, San Francisco
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma, Non-Hodgkin View
None Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Relapsed View
None Refractory View